Specialty Pharmacy

Debate continues around eligibility requirements for pricey new high cholesterol drug class.

Novel kinase cascade found to regulate cancer growth.

Heather Bonome, PharmD, director of Pharmacy Segment at URAC, discusses URAC specialty practice standards.

Sprycel label now includes 5-year first-line efficacy and safety data in adults with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia.

Low bleeding rates found with intervals of up to 2 weeks between infusions.

Company alleged to have marketed products as viable treatments for cancer, malaria, herpes, and heart disease.

Experimental drug shows promise in recent study.

The FDA has approved Baxter and Water Street's cefazolin 2 g injection in a frozen premix, providing another cephalosporin antibacterial option for preoperative prophylaxis treatment.

Many people who test negative for BRCA1 and BRCA2 harbor other harmful genetic mutations.

Biologics are changing how clinicians make treatment choices.

Outpatient pharmacy spending totaled 20% of total health care expenditures.

New method may help personalize treatments for aggressive cancer.

Follow up care with pulmonologist crucial to health outcomes.

Regular exercise may decrease MS symptoms.

Turnover from novel therapeutic target to model systems in clinical use remains a challenge.

Catch up with the latest news in cancer research.

Research may lead to alternative treatment options.

A number of barriers found in smoking cessation.

About 96% of online pharmacies are noncompliant with federal and state laws or National Association of Boards of Pharmacy (NABP) safety and pharmacy practice standards.

Combining chemotherapy with immune blocker could prevent cancer from growing back.

A look back at the top stories of the week on Specialty Pharmacy Times.

Compound kills breast, prostate, lung, and liver cancer cells without harming healthy cells.

Study suggests rheumatoid arthritis chronicity can be influenced.

Process could improve treatment of diseases such as hemophilia and cystic fibrosis.

Research could aid drug discovery.

Bill authorizes the VA to spend as much as $500 million for hepatitis C treatments.

For more than 25 years, the Midwest AIDS Training + Education Center has educated clinicians who provide care to patients infected with human immunodeficiency virus (HIV) and those at risk for HIV.

Intra-abdominal fat cells associated with the progression of Crohn's disease and ulcerative colitis.